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ABSTRACT 
 
This study was conducted to examine the effects of saffron extract on preventing D-galactose 
and NaNO2 induced memory impairment and improving learning and memory deficits in am-
nestic mice. In this study, the learning and memory functions in ovariectomized mice were 
examined by the one way passive and active avoidance tests. In active avoidance test, training 
in amnestic treated (AT) and amnestic prophylaxis (AP) groups, was improved so that there 
was a significant difference between them and the amnestic control (AC) group. In passive 
avoidance test, animal’s step through latency, as an index for learning, in all test groups was 
significantly greater than control group. Total time spent in dark room (DS), which opposes 
the memory retention ability, in AC was significantly greater than AT group at 1 and 2 hours 
after full training, while there was not any significant difference between this index in AP and 
AT as compared with normal control (NC) group. Our findings indicate that saffron hydro- 
alcoholic extract prevents and improves amnesia induced by D-galactose and NaNO2 in mice.  
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INTRODUCTION 
Alzheimer's disease (AD) and senile 
dementia are the most common age-related 
neurodegenerative disorders which are 
pathologically characterized by a progres-
sive accumulation of senile plaques and 
neurofibrillary tangles in cerebral tissues 
such as hippocampus. Their incidence in-
creases steadily with age, and is 40–50 % in 
those who are over 95 years old (Ganong, 
2012). Oxidative stress is a key factor in 
progression of chronic neural degeneration 
in AD (Gilca et al., 2007; Prigione et al., 
2010; Ansari and Scheff, 2010). It is well 
established that a large number of dietaries 
should be regarded as an effective defense 
against the degenerative effects of oxidative 
agents (Chatterjee et al., 1995; Morse and 
Stoner, 1993; Rogers et al., 1993). The 
dried stigmas of Crocus sativus L. (Saffron) 
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which is a valuable spice, commonly used 
for flavouring and coloring food stuffs, has 
been prescribed for various ailments in tra-
ditional medicine (Abdullaev and Espinosa-
Aguirre, 2004; Srivastava et al., 2010). It 
has been demonstrated that crude saffron 
stigma extract is a potent protective agent 
against genotoxicity and has antitumoural 
effects (Abdullaev and Espinosa-Aguirre, 
2004; Srivastava et al., 2010; Abdullaev, 
2002; Premkumar et al., 2003). The antiox-
idative effect of saffron is considered to be 
a major cause of its anticonvulsant, antide-
pressant and antiinflammatory properties 
(Hosseinzadeh and Khosravan, 2002; Hos-
seinzadeh and Younesi, 2002; Karimi et al., 
2001). Behavioral and electrophysiological 
studies have shown that saffron extract im-
proves cognitive disorders induced by etha-
nol consumption and enhance the intact 
spatial memory and scopolamine-induced 
learning impairment in rats performing the 
Morris water maze task (Abe and Saito, 
2000; Sugiura, et al., 1995c; Hosseinzadeh 
and Ziaei, 2006). Major well known saffron 
constituents considered to have pharmaco-
logical activities are safranal (a volatile 
agent), picrocrocin (a bitter taste com-
pound) and crocetin and its glycoside me-
tabolite “crocin” (dye materials) (Hossein-
zadeh and Noraei, 2009). Of these compo-
nents crocetin and its metabolites are the 
most potent protective agents due to their 
antioxidative effects (Bouvier et al., 2003). 
Due to the presence of protective ingredi-
ents in saffron extract, we conducted to 
evaluate the prophylactic and therapeutic 
effects of saffron crude hydro alcoholic ex-
tract on Alzheimer’s disease in animal 
model.  
 
MATERIALS AND METHODS 
Surgical procedure and amnesia induction 
This study was run according to the 
Shahid Sadoughi Medical University Ani-
mal Ethic Committee guide for animal care 
which is in accordance with the internation-
ally accepted principles for laboratory ani-
mal use and care mentioned by the Europe-
an Community guidelines. 12 weeks old 
Balb/c mice weighting 25-30 gs were anes-
thetized by intraperitoneal (i.p.) injection of 
45 mg/kg Thiopental sodium (Rotexmedica, 
trittau, Germany, Batch no. S 10318) and 
surgically undergone a bilateral ovariecto-
my. After 1 week full recovery, 40 ovariec-
tomized mice were divided randomly and 
equally into 4 groups (normal control/NC, 
amnestic treated/AC, amnestic prophylax-
is/AP and amnestic treated/AT) for each 
test. Amnesia was induced by intraperito-
neal injection of 120 mg/kg D-galactose 
(Sinopharm Chemical Reagent Co. China) 
and 90 mg/kg NaNO2 (Merck, Germany) 
for 60 consecutive days (Hua et al., 2007; 
Zhang et al., 2006).  
 
Treatments 
Animals allocated for AP survey re-
ceived 30 mg/kg/day saffron extract (i.p.) 
along with the amnesia induction protocol. 
AT group received the same amount of saf-
fron extract for (i.p.) 15 consecutive days 
after amnesia induction. Animals in NC and 
AC groups received equivalent volume 
(10 ml/kg, i.p.) of distilled water.  
 
Extraction 
To yield the hydro alcoholic extract, 
12 g grounded saffron (kindly supplied by 
Novin Saffron co, Mashhad, Iran) were 
mixed with 180 ml 80 % ethanol in a perco-
lator and the extraction followed after 48 h, 
then the extract was dried using a rotary 
evaporator device (Samsam-Shariat, 2002).  
 
Apparatus 
The learning and memory functions in 
mice were examined by the "one way active 
& passive avoidance learning and memory" 
tests in a Shuttle box apparatus (Galindo et 
al., 2008; Pitsikas and Sakellaridis, 2006). 
The apparatus is a rectangular box with two 
distinct compartments measuring 22 x 21 x 
22 cm and separated by a sliding door. The 
walls and lid of safe compartment was 
made of white-colored acrylic plates while 
the shock compartment with the dark ones. 
Two stainless steel plates (22*20 cm) were 
obliquely embedded in the side walls of 
each compartment, apart from each other by 
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20 cm at the top and 1 cm at the bottom. A 
10-W red light bulb and a buzzer (70 dB, 
760 Hz) were located in the top of front 
wall of the safe room. The stainless steel 
plates in the dark compartment were con-
nected to a square-pulse stimulator (Grass 
model no.S-48) in series with a constant 
current unit (Grass model no. CCU-1A) by 
which a reproducible, aversive electric foot 
shock of 1 mA and 1 second duration could 
be delivered when the mice are in contact 
with both plates. 
 
Experimental procedures 
Active avoidance test: One-way active 
avoidance test was performed basically as 
described by Galindo et al. (2008). In train-
ing or learning session, each animal was 
placed in the dark room with its head to-
wards the wall opposite to the sliding door 
and the lid was closed. Immediately the 
door between the compartments was 
opened and two initial conditioned stimuli 
(CS) sound and light flash were applied 
simultaneously. If the animal crossed to the 
white room during 10 s, a "shock free" trial 
was scored (avoidance). If the animal failed 
to cross to the white room within 10 s, an 
electric foot shock ( 0.4 mA), as an uncon-
ditioned stimulus (US), was continually ap-
plied until leaving the dark room and a 
"shock" trial was assigned (escape). Fol-
lowing the entrance of animal into the safe 
room, the sliding door was closed and after 
30 s rest in this room the next trial was 
started. Maximum duration for electric 
shock delivery was 10 s, so if the animal 
avoids leaving the shock compartment dur-
ing this period, stimulation was stopped and 
the animal was manually conducted to the 
white room to follow a new trial. In this ex-
periment 90 trials per animal were per-
formed in 3 successive days (3 sessions and 
10 trials in each session per day) and the 
mean number of "shock free" trials was 
considered as an index for learning. In 4th 
day, all animals were trained to acquire at 
least 70 % of full learning (i.e. for each 10 
trials at list in 7 trials the animal would 
leave the dark side without receiving any 
foot shock). From this point, evaluation of 
memory retention followed for 3 successive 
days, by the same procedure used in the 
training session without any foot shock, af-
ter 1 and 3 weeks. In these sessions also the 
mean number of "avoidance" trials was 
considered as the index of memory consoli-
dation. 
Passive avoidance test: One-way pas-
sive avoidance test was essentially carried 
out according to Saxena et al. (2008). The 
test was initiated by acclimatization to the 
shuttle box by placing each animal to the 
light room with its head toward the wall 
opposite to the interconnected door. When 
the animal turned toward the dark room the 
door was opened in coincidence with sound 
and light flash display. Upon complete en-
trance to the dark room, the door was 
closed and after 30 s the animal was re-
turned to its home cage. Adaptation trial 
was repeated 3 times with 30 minutes inter 
trial interval. 30 minutes after the last adap-
tation trial, the training trial was run as the 
same as previous except that a mild foot 
shock (0.5 mA; for 10 s) was delivered im-
mediately after the animal arrived to the 
dark room with closed door. After applying 
the aversive stimulus the door was opened 
in order the harassed animal could escape 
the electrified compartment and brought to 
its home cage. Two minutes after the train-
ing trial learning test was carried out by in-
troducing each animal to light room and the 
initial time spend to completely enter the 
dark room (step through latency/STL) with-
in 2 min was recorded. Following this ses-
sion, another training session was repeated 
while the animals remained in the apparatus 
and received a foot-shock upon re-entrance 
to the dark room. Full training trial was 
terminated when the mouse achieved full 
acquisition (i.e. when the mouse stayed in 
the light room for 2 consecutive minutes). 
The retention assay was performed 1 h, 2 h, 
24 h, 1 week and 1 month after the full 
training session similar to the learning ses-
sion. In these sessions, the initial time 
spend by each animal to completely enter 
the dark room (Retention Time/RT), num-
ber of relocating (RLN) and total time spent 
in dark (DS) and light (LS) rooms within 5 
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min were recorded. All behavioral tests 
were performed by blinded experimenters 
about the animal treatments. 
 
Statistical analysis 
In this study shock free/avoidance re-
sponses in active avoidance test were ex-
pressed as mean ± standard error of mean. 
These data were analyzed by two way anal-
ysis of variance (2 way ANOVA) followed 
by Bonferroni post test, repeated measures 
analysis of variance (ANOVA) followed by 
Tukey's multiple comparisons tests and 
Kruskal-Wallis followed by Dunn's multi-
ple comparison test. In passive avoidance 
test, all data are presented as mean ± SEM 
and were statistically analyzed by Kruskal-
Wallis followed by Dunn's multiple com-
parison test. All statistical tests were two-
tailed and P < 0.05 was considered as the 
statistically significant level. 
 
RESULTS 
Active avoidance test 
In active avoidance test, the avoidance 
index in all groups was progressively in-
creased during 3 successive days of training 
session, except for the AC group which ex-
hibited a decrease in avoidance response 
during this session (Table 1). Globally in 
training session, the avoidance response in 
AC group significantly diminished as com-
pared to the NC group (1.933 ± 0.542 vs. 
13.93 ± 1.887, p ≤ 0.001, Figure 1), while 
in AT and AP groups, training was im-
proved so that there was a significant dif-
ference between them and the AC group 
(17.47 ± 1.693 and 8.333 ± 1.485 vs. 1.933 
± 0.542, p ≤ 0.001 and p ≤ 0.05 respective-
ly, Figure 1). Although the training avoid-
ance response in AT and AP groups was the 
same as the NC group, mean avoidance in 
AP group was significantly lower than the 
AT group (8.333 ± 1.485 vs. 17.47 ± 1.693, 
p ≤ 0.01, Figure 1). There was no difference 
in avoidance responses between AT, AP 
and NC groups as compared to each other, 
1 and 3 weeks after the training session, but 
the memory retention in AC groups was 
significantly less than other groups (p ≤ 
0.05, Figures 2 and 3).  
 
Table 1: The avoidance index (Mean ± SEM) in 
different groups during 3 successive days of 
active avoidance training session (n=10) 
 
 Training
days 
 
Groups 
1st day 2nd day 3rd day 
Normal  
control 
6.2 ± 2.0 16.8*,a ± 
2.7 
18.8*,a,b 
± 1.7 
Amnestic 
control 
4.4 ± 1.3 0.8* ± 0.2 0.6* ± 
0.4 
Amnestic 
treated 
10.8a,b ± 
1.9 
19.2*a,b ± 
2.3 
22.4*,a,b 
± 1.6 
Amnestic 
prophylaxis 
2.6 ± 0.9 11.2*,a ± 
2.1 
11.2*,a ± 
2.3 
*Indicates the significant difference in avoid-
ance trials as compared to the 1st day of train-
ing session for each group, using repeated 
measures analysis of variance (ANOVA) fol-
lowed by Tukey's multiple comparisons tests. 
a and b indicate the significant differences in 
avoidance trials as compared to the AC and AP 
groups respectively, using two way analysis of 
variance (2 way ANOVA) followed by Bonferro-
ni post test.  
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Figure 1: Avoidance responses 
of different groups in active 
avoidance training session 
(n=10). a and b indicate the signif-
icant differences in avoidance 
trials as compared to the AC and 
AP groups respectively, using 
repeated measures analysis of 
variance (ANOVA) followed by 
Tukey's multiple comparisons 
tests.  
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Passive avoidance test  
In passive avoidance test, animal’s STL, 
as an index for learning, in NC, AC, AP 
and AT groups were 118.2 ± 1.8, 57.9 ± 
5.9, 109 ± 11 and 109.3 ± 10.7 respectively. 
STL in all test groups was significantly 
greater than control group (p < 0.05, Fig-
ure 4).  
The retention time (RT) as the major 
index for memory consolidation at 1 h, 2 h, 
24 h, 1 week and 1 month after full training 
session for different groups is shown in ta-
ble 2. There wasn't any significant differ-
ence in memory retention among different 
groups 1 week after training, but RT in AT 
and NC groups was significantly greater 
than AC group (300 ± 0.0 vs. 86.8 ± 53.44, 
p < 0.05). 1 h fallowing full training ses-
sion, RT in AC was significantly less than 
other 3 groups (Table 2, p < 0.05). Total 
time spent in dark room (DS), which op-
poses the memory retention ability, in AC 
was significantly greater than AT group at 1 
and 2 hours after full training (p < 0.05), 
while there was not any significant differ-
ence between this index in AP and AT as 
compared with NC group (Table 3, 
p < 0.05). Another index which evaluated in 
passive avoidance test was the number of 
relocating between light and dark rooms, 
which in AC was significantly greater than 
the AT and NC groups 1 h after the full 
training session (Table 4, p < 0.05). 
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Figure 2: A comparison between 
the active avoidance responses 
in different groups during 3 suc-
cessive days of short term 
memory session (n=10). a and b 
indicate the significant difference 
by p < 0.01 and p < 0.001 re-
spectively, as compared with the 
AC group according to Kruskal-
Wallis and Dunn's multiple com-
parison tests. 
Figure 3: A comparison between 
the active avoidance responses 
in different groups during 3 suc-
cessive days of long term 
memory session (n=10). a, b and c 
are indicative of significant differ-
ence by p < 0.05, p < 0.01 and 
p < 0.001 respectively, as com-
pared with the AC group accord-
ing to Kruskal-Wallis and Dunn's 
multiple comparison tests. 
Figure 4: Step through latency 
(STL) in different groups during 
passive avoidance learning ses-
sion (n=10). * indicates the signif-
icant difference (p < 0.05) as 
compared with the AC group ac-
cording to Kruskal-Wallis and 
Dunn's multiple comparison 
tests. 
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Table 2: A comparison between the retention time* (RT) in different groups 1 h, 2 h, 24 h, 1 week and 
1 month after full training session of passive avoidance test (n=10) 
Groups 
Sessions 
amnestic prophylaxis amnestic treated amnestic control Normal control 
RT 1st h 271.6a ± 28.4 283.2a ± 16.8 11.4 ± 0.93 281.2a ± 18.3 
RT 2nd h 228.2 ± 44.3 300a ± 0.0 86.8 ± 53.4 300a ± 0.0 
RT 24th h 219.4 ± 56.9 203.4 ± 50.5 221.4 ± 55.2 234.6 ± 29.9 
RT 1 week 79.8 ± 55.7 148.6 ± 62.8 128.6 ± 70.0 164 ± 16.6 
RT 1 month 89.4 ± 54.5 180.4 ± 30.3 240.6 ± 59.4 130.4 ± 69.5 
* Data are presented as means ± SEM.  
a Indicates the significant difference (p<0.05) as compared with the AC group according to Kruskal-
Wallis and Dunn's multiple comparison tests 
 
 
Table 3: A comparison between the time spent in dark room* (DS), in different groups 1 h, 2 h, 24 h, 
1 week and 1 month after full training session of passive avoidance test (n=10) 
Groups 
Sessions 
amnestic prophylaxis amnestic treated amnestic control Normal control 
DS 1st h 22 ± 22 4.8a ± 4.8 94.8 ± 1.16 0.8 ± 0.5 
DS 2nd h 12.8 ± 8.1 0a ± 0.0 106.4 ± 41.9 0a ± 0 
DS 24th h 2.6 ± 2.1 13.8 ± 7.1 33.6 ± 26.9 29.4 ± 21.4
DS 1 week 43.6 ± 28.9 43.6 ± 19.0 15.8 ± 8.2 44.8 ± 17.2 
DS 1 month 55 ± 30.2 43.8 ± 13.5 28.2 ± 28.2 52.2 ± 33.1 
* Data are presented as means ± SEM.  
a Indicates the significant difference (p<0.05) as compared with the AC group according to Kruskal-
Wallis and Dunn's multiple comparison tests 
 
Table 4: A comparison between the number of relocating* (RLN), between light and dark rooms, in 
different groups 1 h, 2 h, 24 h, 1 week and 1 month after full training session of passive avoidance test 
(n=10) 
Groups 
Sessions 
amnestic prophylaxis amnestic treated amnestic control Normal control 
RLN 1st h 1a ± 1 1.2a ± 1.2 6 ± 0 0.8a ± 0.5
RLN 2nd h 0.8 ± 0.5 1.8 ± 0.9 4 ± 2.4 3.8 ± 2.0 
RLN 24th h 0.8 ± 0.5 1.8 ± 0.9 42.429 3.8 ± 2.0 
RLN 1 week 7.2 ± 3.3 6.2 ± 2.8 5 ± 3.2 10 ± 2.2 
RLN 1 month 11.6 ± 5.2 3.8 ± 1.4 6.4 ± 6.4 10 ± 4.9 
* Data are presented as means ± SEM.  
a Indicates the significant difference (p<0.05) as compared with the AC group according to Kruskal-
Wallis and Dunn's multiple comparison tests 
 
 
DISCUSSION  
Our findings indicated that chronic sys-
temic administration of hydro alcoholic ex-
tract of Crocus sativus L. in both active and 
passive avoidance tests could prevent and 
treat the learning impairment and memory 
deficit induced by D-galactose and NaNO2 
in adult male mice. The enhancement of 
memory retention in active avoidance test 
was more persistent than in passive avoid-
ance. This may be due to the greater fre-
quency of foot shock delivery in training 
session of active avoidance test which 
could be as much as 90 shock/day and for 3 
successive days instead of only 1 shock in 
passive avoidance test. Although, based on 
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our literature review this is for the first time 
that the prolonged systemic administration 
of saffron extract is used to evaluate its 
prophylaxis and therapeutic effect on a 
model of chemically induced cognitive def-
icit, its findings globally supports previous 
studies regarding enhancing effect of saf-
fron and its major constituents on learning 
and memory consolidation processes.  
According to the literature review, 
Zhang et al. (1994), for the first time re-
ported that the alcohol extract of pistils of 
Crocus sativus L. improves learning and 
memory in mice. This finding was further 
supported by Sugiura et al. (1995c), who 
reported that oral administration of saffron 
extract and its major constituent, crocin, 
alone had no effect on learning behavior of 
mice in passive avoidance test, but 
significantly improved ethanol-induced im-
pairment of memory acquisition. They also 
suggested that, in vivo oral or Intracerebro-
ventricular administration of crocin or its in 
vitro application on hippocampal brain slic-
es, significantly antagonized the inhibitory 
effect of ethanol on long-term potentiation 
(LTP) which is a mechanism underlying 
memory formation (Sugiura et al., 1995a, 
b). It has been also suggested that alcohol 
extract of Crocus sativus L. can prevent 
aversive effects induced by ethanol and its 
metabolite on neural activity in the dentate 
gyrus of anesthetized rats (Abe et al., 
1999).  
Hosseinzadeh and Ziaei (2006) demon-
strated that, the Crocus sativus stigma 
aqueous extract, and crocin inhibited the 
hyoscine impaired acquisition in rats per-
forming the Morris water maze task but did 
not affect the animal's intact memory. In the 
same way, the extract could inhibit mor-
phine-induced impairments on spatial learn-
ing and memory in rats (Haghighizad et al., 
2008). In a research report the antagonizing 
effect of saffron extract on memory im-
pairments, in the object recognition and the 
step-through passive avoidance task, was 
demonstrated in the rat (Pitsikas and Sakel-
laridis, 2006). In this study Pitsikas and 
Sakellaridis (2006), used a single injection 
of 3 low doses of saffron aqueous extract 
and the animal's memory was also de-
stroyed by a single dose of scopolamine 
administration, while in our study we used 
a low dose of hydro alcoholic extract 
(30 mg/kg) for a long period of 60 days in 
the case of prevention and 15 days for ther-
apeutic evaluation. Pitsikas et al. (2007), 
proposed that the memory enhancing effect 
of saffron extract is due to the crocins 
which are water soluble carotenoid constit-
uents of this plant. Khalili et al. (2009) also 
have shown that aqueous Crocus sativus L. 
extract administration significantly inhibit-
ed learning and memory deficit in strepto-
zotocin-induced dementia in passive avoid-
ance test.  
Recently it has been proposed that the 
positive effect of saffron on learning and 
memory processing is due to the antioxi-
dant activity of its active components (Pa-
pandreou et al., 2011). It has also been sug-
gested that crocins derived from Crocus 
sativus L. significantly increase the retinal 
and choroidal blood flow and improve age 
related macular degeneration (Xuan et al., 
1999). In the present study the amnesia in-
duction was performed by prolonged intra-
peritoneal administration of D-galactose 
and NaNO2 in ovariectomized mice. 
NaNO2 causes hypoxia and disability of 
consciousness in mice while D-galactose 
leads to an increase in free radicals and the 
combination of these 2 drugs induces a sig-
nificant neuronal damage and atrophy in the 
mice brain hippocampus (Fang and Liu 
2007). Therefore the protective effects of 
saffron extract against this model of learn-
ing and memory impairment can be due to 
its oxidative scavenger and/or increasing 
the cerebral blood flow which needs to be 
further investigated.  
 
CONCLUSION 
According to our findings and previous 
evidences, it can be postulated that saffron 
and its active constituents can be potentially 
new drugs in the treatment of cognitive dys-
functions such as Alzheimer's disease and 
should be further studied through clinical 
trial investigations. 
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